Posted in the comments by Adam Collyer:
From the Alcohol Concern website:
"The Alcohol Harm Map, produced by Alcohol Concern in partnership with the pharmaceutical company Lundbeck Ltd. The purpose of the map is to reveal the real harm and cost of alcohol at a local level, so that local authorities and local health providers can ensure that alcohol prevention and treatment services are available to those with drinking problems..."
From Lundbeck's website, one of their UK products is called Selincro (generic name nalmefene).
And from the website of NICE, the National Institute for Health and Clinical Excellence (the government agency which recommends which products should be used by the NHS):
"NICE has been asked to appraise nalmefene for reducing alcohol consumption in people with alcohol dependence in a single technology appraisal. The expected date of publication of the appraisal is November 2014."
Perfect timing it seems...
Viewer drought
34 minutes ago
2 comments:
Nice example of Big Pharma owning a charity.
According to Wikipedia nalmefene has been used to treat addiction to shopping. Another blow for the big supermarkets.
Post a Comment